EFFICACY AND TOLERABILITY OF FLUPIRTINE VERSUS TRAMADOL IN THE TREATMENT OF MODERATE CHRONIC LOW BACK PAIN
Objective: The objective of the study was to assess and compare the efficacy and tolerability of flupirtine versus tramadol in patients with chronic moderate low back pain (LBP).
Materials and Methods: A prospective study was conducted in the outpatient department of orthopaedics at tertiary care hospital, Rajamahendravarm. After meeting the inclusion criteria, a total of 60 patients were randomly allocated to tablet flupirtine 100 mg in Group A and tablet tramadol 50 mg in Group B. The efficacy of the study drugs was assessed at baseline and the end of treatment by numerical rating scale11, visual analog scale-100 mm, physician’s, and patient’s global assessment. Statistical analysis was done using paired and unpaired t-test and data were presented as mean±standard deviation. Adverse drug reactions were monitored during the treatment.
Results: The study results showed that 90% of the patients in Group A and 78% of the patients in Group B had shown a good response to their respective drugs. 30% of flupirtine group patients reported adverse drug reactions which were mild.
Conclusion: Both the drugs are effective in the treatment of moderate chronic LBP, but the advantage of flupirtine was, the incidence of adverse drug reactions was less when compared to tramadol group.
2. Balagué F, Mannion AF, Pellisé F, Cedraschi C. Non-specific low back pain. Lancet 2012;379:482-91.
3. Meucci RD, Fassa AG, Faria NM. Prevalence of chronic low back pain: Systematic review. Rev Saude Publica 2015;49:S0034.
4. Taimela S, Kujala UM, Salminen JJ, Viljanen T. The prevalence of low back pain among children and adolescents. A nationwide, cohort-based questionnaire survey in Finland. Spine (Phila Pa 1976) 1997;22:1132-6.
5. Chou R, Huffman LH, American Pain Society, American College of Physicians. Medications for acute and chronic low back pain: A review of the evidence for an American pain society/American college of physicians clinical practice guideline. Ann Intern Med 2007;147:505-14.
6. Devulder J. Flupirtine in pain management: Pharmacological properties and clinical use. CNS Drugs 2010;24:867-81.
7. Ringe JD, Miethe D, Pittrow D, Wegscheider K. Analgesic efficacy of flupirtine in primary care of patients with osteoporosis related pain. A multivariate analysis. Arzneimittelforschung 2003;53:496-502.
8. Schug SA. The role of tramadol in current treatment strategies for musculoskeletal pain. Ther Clin Risk Manag 2007;3:717-23.
9. Devi YB, Sumanth KS, Raju VB, Gandhi BM, Srinivas K. A new reversed-phase high-performance liquid chromatography method development and validation for the simultaneous estimation of ketorolac tromethamine and tramadol hydrochloride in pharmaceutical dosage forms. Asian J Pharm Clin Res 2017;10:186-90.
10. McCormack HM, Horne DJ, Sheather S. Clinical applications of visual analogue scales: A critical review. Psychol Med 1988;18:1007-19.
11. Huskisson EC. Measurement of pain. Lancet 1974;2:1127-31.
12. Rodriguez CS. Pain measurement in the elderly: A review. Pain Manag Nurs 2001;2:38-46.
13. Farrar JT, Young JP Jr. LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001;94:149-58.
14. Oded H, Friedlander A, Gordon B, Arzi H. The relationship between the body mass index, body height and the prevalence of low back pain in young adults. Spine J 2013;11:92.
15. Philip BK. Parametric statistics for evaluation of the visual analog scale. Anesth Analg 1990;71:710.
16. Uberall MA, Mueller-Schwefe GH, Terhaag B. Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: Results of SUPREME, a prospective randomized, double-blind, placebo and active-controlled parallel-group phase IV study. Curr Med Res Opin 2012;28:1617-34.
17. Li C, Ni J, Wang Z, Li M, Gasparic M, Terhaag B, et al. Analgesic efficacy and tolerability of flupirtine vs. Tramadol in patients with subacute low back pain: A double-blind multicentre trial*. Curr Med Res Opin 2008;24:3523-30.
18. Banerjee M, Bhattacharyya K. Comparative study of efficacy and tolerability of flupirtine versus tramadol in non-steroidal anti-inflammatory drug intolerant mechanical low back pain. Indian J Rheumatol 2012;7:135-40.
19. Fabule J, Adebajo A. Comparative evaluation of cardiovascular outcomes in patients with osteoarthritis and rheumatoid arthritis on recommended doses of nonsteroidal anti-inflammatory drugs. Ther Adv Musculoskelet Dis 2014;6:111-30.
20. Nasare NV, Banerjee BD, Deshmukh PS, Mediratta PK, Ahmed RS, Saxena AK, et al. The impact of pharmacogenetics on adverse drug reactions to predict the efficacy of tramadol monotherapy for the treatment of post herpetic neuralgia patients. Int J Pharm Pharm Sci 2014;6:89-96.
21. Scheef W. Analgesic efficacy and safety of oral flupirtine in the treatment of cancer pain. Postgrad Med J 1987;63 Suppl 3:67-70.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.